Brents, L. K., Gallus-Zawada, A., Radominska-Pandya, A., Vasiljevik, T., Prisinzano, T. E., Fantegrossi, W. E., . . . Prather, P. L. (2012). Monohydroxylated metabolites of the K2 synthetic cannabinoid JWH-073 retain intermediate to high cannabinoid 1 receptor (CB1R) affinity and exhibit neutral antagonist to partial agonist activity.

Brents, Lisa K., Anna Gallus-Zawada, Anna Radominska-Pandya, Tamara Vasiljevik, Thomas E. Prisinzano, William E. Fantegrossi, Jeffery H. Moran, et Paul L. Prather. Monohydroxylated Metabolites of the K2 Synthetic Cannabinoid JWH-073 Retain Intermediate to High Cannabinoid 1 Receptor (CB1R) Affinity and Exhibit Neutral Antagonist to Partial Agonist Activity. 2012.

Brents, Lisa K., et al. Monohydroxylated Metabolites of the K2 Synthetic Cannabinoid JWH-073 Retain Intermediate to High Cannabinoid 1 Receptor (CB1R) Affinity and Exhibit Neutral Antagonist to Partial Agonist Activity. 2012.